Preface [Hot Topic: Current Status of Neuroprotection in Traumatic Brain Injury (Executive Editors: Maria Mataro and Juan Sahuquillo)]
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
i-i
Author(s):
Maria Mataro and Juan Sahuquillo
Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2131-2143
Author(s):
Enriquez P and Bullock R.
Microdialysis in Neurointensive Care
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2145-2152
Author(s):
Urban Ungerstedt and Elham Rostami
Importance of Aquaporins in the Physiopathology of Brain Edema
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2153-2161
Author(s):
Jose L. Venero, Alberto Machado and Josefina Cano
Arterial Hyperoxia in Severe Head Injury: A Useful or Harmful Option?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2163-2176
Author(s):
O. L. Alves, W. P. Daugherty and M. Rios
Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2177-2183
Author(s):
Anat Biegon
Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2185-2192
Author(s):
W. M. Armstead
Moderate Hypothermia in the Management of Severe Traumatic Brain Injury: A Good Idea Proved Ineffective?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2193-2204
Author(s):
J. Sahuquillo, M. P. Mena, A. Vilalta and M. A. Poca
Neuroprotection by the α2-Adrenoceptor Agonist, Dexmedetomidine, in Experimental Stroke Models
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
1
Page:
117-122
Author(s):
Kirsi Puurunen, Jukka Jolkkonen and Juhani Sivenius
Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery
Journal:
Current Vascular Pharmacology
Volume:
2
Page:
281-299
Author(s):
Silvia Muro, Michael Koval and Vladimir Muzykantov